3

FORM 3 SUBMISSION

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filed: October 5, 2021
Period of Report: October 5, 2021
Accession Number: 0000899243-21-039278

View Document ↗ View on SEC.gov ↗